Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Chevron
CVX
|
+$718M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$469M |
| 4 |
Shopify
SHOP
|
+$439M |
| 5 |
Meta Platforms (Facebook)
META
|
+$401M |
Top Sells
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 3 |
Tesla
TSLA
|
+$543M |
| 4 |
Verizon
VZ
|
+$535M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.81% |
| 3 | Consumer Staples | 11.14% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3951
Moving iMage Technologies
MITQ
$11.6M
| $65K | ﹤0.01% |
49,800
-69,051
| -58% | -$90.1K |
|
|
FWP
3952
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $65K | ﹤0.01% |
14,500
-10,000
| -41% | -$44.8K |
|
|
PTN
3953
DELISTED
Palatin Technologies
PTN
| $64K | ﹤0.01% |
9,076
+7,216
| +388% | +$50.9K |
|
3954
SiriusXM
SIRI
$7.99B
| $64K | ﹤0.01% |
+1,040
| New | +$64K |
|
3955
IZEA Worldwide
IZEA
$64.5M
| $63K | ﹤0.01% |
17,450
-48,200
| -73% | -$174K |
|
|
MDRR
3956
Medalist Diversified REIT
MDRR
$17.8M
| $63K | ﹤0.01% |
4,750
+900
| +23% | +$11.9K |
|
3957
Neuropace
NPCE
$322M
| $63K | ﹤0.01% |
+12,700
| New | +$63K |
|
3958
SOPHiA GENETICS
SOPH
$215M
| $63K | ﹤0.01% |
+17,500
| New | +$63K |
|
3959
Synlogic
SYBX
$17.1M
| $63K | ﹤0.01% |
3,667
+247
| +7% | +$4.24K |
|
|
PTE
3960
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $63K | ﹤0.01% |
43,322
+39,042
| +912% | +$56.8K |
|
|
CFRX
3961
DELISTED
ContraFect Corporation
CFRX
| $63K | ﹤0.01% |
+258
| New | +$63K |
|
|
ASPU
3962
DELISTED
ASPEN GROUP, INC.
ASPU
| $62K | ﹤0.01% |
63,277
+52,177
| +470% | +$51.1K |
|
|
OKUR
3963
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$33.8M
| $61K | ﹤0.01% |
+2,300
| New | +$61K |
|
3964
Zenvia
ZENV
$84.4M
| $60K | ﹤0.01% |
28,300
+12,600
| +80% | +$26.7K |
|
|
BLRX
3965
BioLineRX
BLRX
$16.1M
| $59K | ﹤0.01% |
1,144
-540
| -32% | -$27.9K |
|
|
CPAC
3966
Cementos Pacasmayo
CPAC
$575M
| $59K | ﹤0.01% |
+12,464
| New | +$59K |
|
3967
Forian
FORA
$66M
| $59K | ﹤0.01% |
+13,500
| New | +$59K |
|
|
SANW
3968
DELISTED
S&W Seed Co
SANW
| $59K | ﹤0.01% |
3,117
+137
| +5% | +$2.59K |
|
3969
Tempest Therapeutics
TPST
$47.9M
| $59K | ﹤0.01% |
2,100
-992
| -32% | -$27.9K |
|
|
ATHX
3970
DELISTED
Athersys, Inc. Common Stock
ATHX
| $59K | ﹤0.01% |
9,116
-6,083
| -40% | -$39.4K |
|
|
CNTB
3971
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$94.2M
| $58K | ﹤0.01% |
66,900
+43,400
| +185% | +$37.6K |
|
3972
Jiuzi Holdings
JZXN
$49.5M
| $58K | ﹤0.01% |
285
+97
| +52% | +$19.7K |
|
3973
NovaGold Resources
NG
$2.75B
| $58K | ﹤0.01% |
12,100
-603,600
| -98% | -$2.89M |
|
|
RGLS
3974
DELISTED
Regulus Therapeutics
RGLS
| $58K | ﹤0.01% |
28,100
+14,760
| +111% | +$30.5K |
|
3975
Rezolute
RZLT
$714M
| $58K | ﹤0.01% |
+17,900
| New | +$58K |
|